SCHEMBL23748592

SCHEMBL23748592

O=C(CCl)Nc1ccc(Oc2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNF4 P78317 1/20 0.68
FNTA P49354 1/20 0.58
FNTB P49356 1/20 0.58
EPHX2 P34913 2/20 0.53
HTT P42858 3/20 0.52
LMNA P02545 2/20 0.52
MDH1 P40925 1/20 0.52
MDH2 P40926 1/20 0.52
ALDH1A1 P00352 2/20 0.51
MITF O75030 2/20 0.51
TRPV1 Q8NER1 1/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KCNJ5 P48544 1/20 0.51
KCNJ3 P48549 1/20 0.51
RHOC P08134 1/20 0.50
RHOA P61586 1/20 0.50
CYP1A2 P05177 1/20 0.49
GLA P06280 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008934 0.91 EPHX2 (0.63) EPHX2HTTLMNAALDH1A1MITF
SCHEMBL11806908 0.87 RNF4 (0.86) RNF4HTTLMNAALDH1A1MITF
SCHEMBL23748593 0.86 RNF4 (0.66) RNF4FNTAFNTBHTTALDH1A1
SCHEMBL25167513 0.85 RNF4 (0.68) RNF4HTTLMNAALDH1A1MITF
SCHEMBL20941788 0.84 FNTA (0.67) RNF4FNTAFNTBEPHX2ALDH1A1
SCHEMBL9181248 0.81 FNTA (0.55) FNTAFNTBEPHX2LMNAMDH1
SCHEMBL3382618 0.81 RNF4 (1.00) RNF4HTTLMNAALDH1A1MITF
SCHEMBL21392968 0.81 RNF4 (0.76) RNF4FNTAFNTBHTTLMNA
SCHEMBL23660459 0.80 FNTA (0.63) RNF4FNTAFNTBEPHX2HTT
SCHEMBL1945608 0.80 EPHX2 (0.67) RNF4EPHX2ALDH1A1TRPV1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164495-B Covalent targeting of E3 ligases 加利福尼亚大学董事会 2025-04-22 CN disclosed
US-20250120982-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-04-17 US disclosed
US-12161648-B2 Covalent targeting of E3 ligases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-12-10 US disclosed
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-02 US disclosed
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-02 US disclosed
EP-3863642-A1 COVALENT TARGETING OF E3 LIGASES The Regents of the University of California (US) 2021-08-18 EP disclosed
CN-113164495-A Covalent targeting of E3 ligase 加利福尼亚大学董事会 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12161648-B2 Covalent targeting of E3 ligases RNF114, RNF4, RNF168 RNF4 2/4885FNTA 2519/4885FNTB 2845/4885
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES RNF114, RNF4, RNF168 RNF4 2/4885FNTA 2519/4885FNTB 2845/4885
US-20250120982-A1 COVALENT TARGETING OF E3 LIGASES STUB1, XIAP, RBX1 RNF4 13/4885FNTA 2419/4885FNTB 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.